Skip to main content
. 2019 Sep 23;2019(9):CD013435. doi: 10.1002/14651858.CD013435

Ishigaki 2012.

Methods RCT, parallel design
Participants Total number of randomized participants: 49
Inclusion criteria: people with drug‐resistant AF, undergoing catheter ablation
Country: Japan
Interventions Landiolol vs placebo, given after the procedure and continued for 3 days
Outcomes Outcomes measured/reported by study authors: haemodynamic variables; AF
Outcomes relevant to the review: AF
Notes Study published as an abstract with insufficient information to fully assess eligibility. We await publication of the full report to assess eligibility